commit d3b21ff76053a3334c39b3edfd9fa1c605d67a04 Author: sandraabner833 Date: Fri Apr 3 02:16:32 2026 +0800 Add Testosterone Therapy for Hypogonadism Guideline Resources diff --git a/Testosterone-Therapy-for-Hypogonadism-Guideline-Resources.md b/Testosterone-Therapy-for-Hypogonadism-Guideline-Resources.md new file mode 100644 index 0000000..285d5cc --- /dev/null +++ b/Testosterone-Therapy-for-Hypogonadism-Guideline-Resources.md @@ -0,0 +1,11 @@ +
+
Theoretically, prostate screening might exclude a pre-existing tumour during testosterone treatment, but endocrinologists have little experience recognising prostate cancer during digital rectal examination (DRE), which therefore risks harm. It is broadly accepted that testosterone treatment does not increase the risk of developing new prostate cancer. During treatment with [buy testosterone enanthate](http://139.196.179.195:3000/octaviagoodell) replacement, regular blood tests should be carried out to monitor testosterone levels and if necessary, the dose adjusted [best place to buy testosterone](https://focotop.com/@marianmcelroy1?page=about) ensure levels return to the normal range. The results of these blood tests will help distinguish between primary (low testosterone and high gonadotrophins) and secondary (low testosterone and normal or low gonadotrophins) hypogonadism. Some men with normal total testosterone have low free or bioavailable testosterone levels which could still account for their symptoms. Although testosterone replacement therapy is the primary treatment option,  some conditions that cause hypogonadism, such as obesity, can be reversible without [testosterone buy online](https://my.playfre.com/chuhentze7192) therapy. +Another intriguing observation is that prostate-specific antigen (PSA), a marker for prostate cancer, is significantly lower in type 2 diabetics and this is related to their lower plasma testosterone concentrations (46). This is in contrast to what was found in the MMAS study where total testosterone levels were unrelated to all-cause mortality (34,35). In fact, epidemiological analyses have found that HDL levels are positively linked to testosterone levels in middle-aged men. The Massachusetts Male Ageing Study (MMAS) measured a combination of testosterone levels and hypogonadal symptoms and found between 6% and 12% of men had symptomatic androgen deficiency (21). +Over time, low testosterone may cause a man to lose body hair, muscle bulk, cause weak bones (osteoporosis), low red blood cells and smaller testes. The brain and pituitary gland (a small gland at the base of the brain) control the production of [buy testosterone powder](https://tiktub.com/@marianhop74537?page=about) by the testes. It is estimated that approximately 35% of men older than 45 years of age and 30-50% of men with obesity or type 2 diabetes have hypogonadism. +This will not be effective in men whose testes simply cannot synthesize [testosterone online pharmacy](http://175.27.132.111:43000/gaildix4210224/1148deltasongs.com/wiki/Unveiling-the-Human-with-the-Highest-Testosterone-Levels%3A-A-Comprehensive-Exploration) anymore (primary hypogonadism), and the failure of hCG therapy is further support for the existence of true testicular failure in a patient. Male primary or hypergonadotropic hypogonadism is often treated with [buy testosterone online no prescription](http://git.520hx.vip/iucdonette772) replacement therapy if they are not trying to conceive. In any case, the LH and FSH levels will rise in cases of primary hypogonadism or menopause, while they will be low in women with secondary or tertiary hypogonadism. This is because hypogonadism is an abnormality, whereas menopause is a normal change in hormone levels. +These are responsible for the observed signs and symptoms in both males and females. Low androgen (e.g., testosterone) levels are referred to as hypoandrogenism and low estrogen (e.g., estradiol) as hypoestrogenism. "Lifestyle adjustments like improving sleep, reducing stress, losing weight and increasing physical activity can naturally boost [buy testosterone gel online](https://unpourcent.online/@helenephx13192), particularly in borderline or age-related cases," Baumgarten said. +After 1 year, prostate monitoring should conform to standard guidelines for prostate cancer screening based on the race and age of the patient. 3.1 In hypogonadal men who have started testosterone therapy, we recommend evaluating the patient after treatment initiation to assess whether the patient has responded to treatment, is suffering any adverse effects, and is complying with the treatment regimen. 1.1 We recommend diagnosing hypogonadism in men with symptoms and signs of testosterone deficiency and unequivocally and consistently low serum total testosterone and/or free testosteroneconcentrations (when indicated). The benefits of testosterone replacement therapy may include restoring metabolic parameters to the eugonadal state; improving psychosexual function and intellectual capacity, including depression and lethargy; maintaining bone mineral density and reducing bone fractures; improving muscle mass and strength; and enhancing quality of life. Monitoring of the prostate (assessed with DRE and PSA assay) and hematocrit and lipid profile should be repeated during testosterone replacement therapy. Lipid disturbances in [buy testosterone gel online](https://ns2.asso-web.com/lizziecheeke84)-treated male patients are generally not a problem because the ratio of high-density lipoprotein to total cholesterol usually remains constant. +Sometimes a medication called clomiphene citrate is used to treat hypogonadism, but this is not FDA approved for this indication. You should discuss the different options with your physician "your partner in care" to find out which therapy is right for you. They may involve a problem with the testes or with the signal from the brain that controls testosterone secretion. +The authors demonstrated that, [43.143.142.38](http://43.143.142.38:7001/kristopherbarr) as a result of this, approximately 35% of hypogonadal patients did not receive treatment (20). The correlation of voiding symptoms and prostate size is poor, so there may not be any changes in urine flow rates and prostate voiding symptoms. The development of BPH requires androgens, but many studies have failed to show an association with testosterone treatment. Patients with benign prostatic hyperplasia (BPH) treated with androgens are at an increased risk for worsening of signs and symptoms of BPH. Bone mineral density measurement should also be carried out at baseline because hypogonadism is an important cause of male osteoporosis. Men using a testosterone gel should be advised by their healthcare provider on the ways of minimising the risk of testosterone transfer to women and children. +Around the time of puberty, boys with too little testosterone may also have less than normal strength and endurance, and their arms and legs may continue to grow out of proportion with the rest of their body. However, as the testes are impaired or missing, they are not able to respond to the increased levels of gonadotrophins and little or no testosterone is produced. Primary hypogonadism occurs when the low level of [buy testosterone enanthate online](http://218.245.96.10/randidkb482813) is due to conditions affecting the testes. In some cases, it can be difficult to tell if there is a true deficiency of [buy testosterone propionate](https://demo.playtubescript.com/@luigie46559162?page=about), particularly when the levels are in the borderline range. +
\ No newline at end of file